• No results found

[PDF] Top 20 Comprehensive systematic review summary: Treatment of cerebellar motor dysfunction and ataxiaReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

Has 10000 "Comprehensive systematic review summary: Treatment of cerebellar motor dysfunction and ataxiaReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology" found on our website. Below are the top 20 most common "Comprehensive systematic review summary: Treatment of cerebellar motor dysfunction and ataxiaReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology".

Comprehensive systematic review summary: Treatment of cerebellar motor dysfunction and ataxiaReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

Comprehensive systematic review summary: Treatment of cerebellar motor dysfunction and ataxiaReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

... The American Academy of Neurology (AAN) is committed to producing independent, critical, and truthful comprehen- sive systematic reviews ...of, systematic review ...neurologists, ... See full document

9

Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

... “Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and ... See full document

7

Practice guideline summary: Treatment of restless legs syndrome in adultsReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

Practice guideline summary: Treatment of restless legs syndrome in adultsReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

... Results and recommendations: In moderate to severe primary RLS, clinicians should consider pre- scribing medication to reduce RLS symptoms. Strong evidence supports pramipexole, rotigotine, cabergoline, and gabapentin ... See full document

10

Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsyReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the

Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsyReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society

... Lancet Neurology, Neurology Today, and Epileptic Disorders; serves as scientific officer for the Epilepsy Foundation for which New York University receives salary support; and has received travel reimbursement ... See full document

9

Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsyReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the Am

Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsyReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society

... of Neurology at the University of Miami, Miller School of Medicine; receives royalties from Psychiatric Aspects of Epi- lepsy, Treatment of Depression in Neurologic Disorders, and Psychiatric Controversies ... See full document

12

Practice guideline update summary: Acute treatment of migraine in children and adolescentsReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society

Practice guideline update summary: Acute treatment of migraine in children and adolescentsReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society

... the American Headache ...Child Neurology, on a speakers’ bureau for Allergan, and as an in- terviewer for Neurology podcasts; served as site principal in- vestigator for the CHAMP (Childhood and ... See full document

26

Practice guideline update summary: Pharmacologic treatment for pediatric migraine preventionReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society

Practice guideline update summary: Pharmacologic treatment for pediatric migraine preventionReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society

... the Guideline Development, Dissemi- nation, and Implementation Subcommittee by the American Academy of Neurology ...Economic Review Calcitonin Gene-Related Peptide ... See full document

26

Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosisReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosisReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

... reduced treatment response in several ...with treatment intervals shorter than 10 weeks in their study, note the difficulty of comparing treatment efficacy across different indications, and concede that ... See full document

19

Evidence in focus: Nusinersen use in spinal muscular atrophyReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

Evidence in focus: Nusinersen use in spinal muscular atrophyReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

... crucial to independence and quality of life, such as controlling the joystick of a power wheelchair or making communicative gestures. Such patients also face the greatest practical chal- lenges to LP because of severe ... See full document

12

Comprehensive systematic review update summary: Disorders of consciousnessReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology; the American Congress of Rehabilitation Medicine; and the N

Comprehensive systematic review update summary: Disorders of consciousnessReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology; the American Congress of Rehabilitation Medicine; and the National Institute on Disability, Independent Living, and Rehabilitation Research

... this guideline, the term UWS is used synonymously with ...the American Academy of Neurology (AAN) published diagnostic and prognostic guidelines for persistent VS (PVS) 7 following an ... See full document

12

Practice advisory: Etanercept for poststroke disabilityReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

Practice advisory: Etanercept for poststroke disabilityReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

... The investigators determined acceptable effect measures to be a change from pretreatment status after etanercept treatment on any measure of functional ability. When possible, 95% confidence intervals (CIs) were ... See full document

5

Practice guideline summary: Sudden unexpected death in epilepsy incidence rates and risk factorsReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society

Practice guideline summary: Sudden unexpected death in epilepsy incidence rates and risk factorsReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society

... and treatment outcomes for psychogenic nonepileptic seizures,” Tolchin et ...appropriate treatment and ...neurologists review previous EEGs when there is suspicion that a previous “abnormal” EEG may ... See full document

15

Practice guideline: Cervical and ocular vestibular evoked myogenic potential testingReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

Practice guideline: Cervical and ocular vestibular evoked myogenic potential testingReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

... of Neurology, as Editor-in-Chief of Frontiers in Neuro-otology, and as Section Editor of F1000; has received support in the form of a German Federal Ministry of Education and Research grant ...and Treatment ... See full document

10

Practice guideline: Idiopathic normal pressure hydrocephalus: Response to shunting and predictors of responseReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

Practice guideline: Idiopathic normal pressure hydrocephalus: Response to shunting and predictors of responseReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

... advisories, systematic reviews, and other guidance published by the American Academy of Neurology (AAN) and its affiliates are assessments of current scientific and clinical information ... See full document

11

Practice guideline update summary: Vaccine-preventable infections and immunization in multiple sclerosisReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

Practice guideline update summary: Vaccine-preventable infections and immunization in multiple sclerosisReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

... MS treatment with ISIM medications are ...and treatment with these pharmacologic ...before treatment to permit the immune response to ...during treatment and for 2 months after ...during ... See full document

12

Practice guideline update summary: Mild cognitive impairmentReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

Practice guideline update summary: Mild cognitive impairmentReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

... The guideline panel recommends (1) the use of consistent diagnostic criteria for MCI and dementia in clinical trials, to improve the ability to apply and combine results; (2) the inclusion of patient cohorts with ... See full document

11

Summary of comprehensive systematic review: Rehabilitation in multiple sclerosisReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

Summary of comprehensive systematic review: Rehabilitation in multiple sclerosisReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

... advisories, systematic reviews, and other guidance published by the American Academy of Neurology and its affiliates are assessments of current scientific and clinical information provided as ... See full document

9

Practice guideline summary: Use of fMRI in the presurgical evaluation of patients with epilepsyReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

Practice guideline summary: Use of fMRI in the presurgical evaluation of patients with epilepsyReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

... advisories, systematic reviews, and other guidance published by the American Academy of Neurology and its affiliates are assessments of current scientific and clinical information provided as ... See full document

9

Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosisReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosisReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

... most individuals with RRMS ultimately advance to secondary progressive MS (SPMS) if observed for long enough intervals, although disease course is highly variable. e44 People with MS who are stable on DMTs may question ... See full document

14

Practice guideline summary: Reducing brain injury following cardiopulmonary resuscitationReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

Practice guideline summary: Reducing brain injury following cardiopulmonary resuscitationReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

... advisories, systematic reviews, and other guidance published by the American Academy of Neurology and its affiliates are assessments of current scientific and clinical information provided as ... See full document

11

Show all 10000 documents...